Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: Feasibility and durability

被引:185
作者
Clagett, GP
Valentine, RJ
Hagino, RT
机构
[1] Vascular Surgery Division, Texas University SW Medical Center, Dallas, TX 75235-9157
关键词
D O I
10.1016/S0741-5214(97)70347-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Autogenous aortoiliac/femoral reconstruction with superficial femoral-popliteal veins (SFPVs) has been successfully used to treat prosthetic infection and failure, but outcome data are scant. In this prospective, observational study, we hypothesized that (1) replacement of the aortoiliac/femoral system with SFPVs could be performed with perioperative morbidity and mortality rates equal to those of conventional methods; (2) long-term patency rates would be excellent; (3) limb salvage rates would be correspondingly high; (4) aneurysmal degeneration would not occur; and (5) venous morbidity would be minimal. Methods: Since 1990, 41 patients have undergone complete or partial aortoiliac/femoral reconstruction with 63 SFPVs with a mean (+/- SD) follow-up time of 32 +/- 21 months. With the exception of two patients lost to follow-up, all have been observed at 6-month intervals with clinical examination and noninvasive tests. Results: There were no immediate operative deaths, but three patients (7.3%) died of multisystem organ failure after 1 month. Forty-nine percent of patients had significant perioperative complications including amputation (5%), compartment syndrome (12.3%), and pulmonary embolism (2.4%). Most patients (85%) had multilevel occlusive disease, and the mean SVS/ISCVS runoff score for the group was 4.9 +/- 2.6 (1 = normal, 10 = no runoff). Fifty-eight percent of all distal anastomoses were end-to-end, and in 68% of limbs the profunda femoris artery or superficial femoral artery was the sole runoff vessel. At 5 years, the cumulative secondary patency rate was 100%; primary patency rate, 83%; limb retention rate, 86%; and survival rate, 69%. Pour patients had permanent Limb edema controlled by compression stockings but none have had venous ulceration. There has been no aneurysmal dilation of SFPV grafts, and mean diameter shown by serial duplex imaging at 6 months (10.8 +/- 1.1 mm) was not significantly different from that at 60 months (7.8 +/- 1.1 mm). Conclusions: Aortoiliac/femoral reconstruction with SFPVs is a successful and durable option for infection and other complex aortic problems.
引用
收藏
页码:255 / 266
页数:12
相关论文
共 27 条
  • [1] Bacourt F, 1992, Ann Vasc Surg, V6, P119, DOI 10.1007/BF02042731
  • [2] CREATION OF A NEO-AORTOILIAC SYSTEM FROM LOWER-EXTREMITY DEEP AND SUPERFICIAL VEINS
    CLAGETT, GP
    BOWERS, BL
    LOPEZVIEGO, MA
    ROSSI, MB
    VALENTINE, RJ
    MYERS, SI
    CHERVU, A
    [J]. ANNALS OF SURGERY, 1993, 218 (03) : 239 - 249
  • [3] CLAGETT GP, 1996, ARTERIAL SURG MANAGE, P187
  • [4] EHRENFELD WK, 1979, SURGERY, V85, P82
  • [5] AUTOGENOUS VEIN GRAFTS FOR FEMOROFEMORAL REVASCULARIZATION IN CONTAMINATED OR INFECTED FIELDS
    HAKAIM, AG
    HERTZER, NR
    OHARA, PJ
    KRAJEWSKI, LP
    BEVEN, EG
    [J]. JOURNAL OF VASCULAR SURGERY, 1994, 19 (05) : 912 - 915
  • [6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [7] SECONDARY AORTOENTERIC FISTULA - CONTEMPORARY OUTCOME WITH USE OF EXTRAANATOMIC BYPASS AND INFECTED GRAFT EXCISION
    KUESTNER, LM
    REILLY, LM
    JICHA, DL
    EHRENFELD, WK
    GOLDSTONE, J
    STONEY, RJ
    [J]. JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) : 184 - 196
  • [8] MANAGEMENT OF PRIMARY AORTIC GRAFT INFECTION BY EXTRAANATOMIC BYPASS RECONSTRUCTION
    LEHNERT, T
    GRUBER, HP
    MAEDER, N
    ALLENBERG, JR
    [J]. EUROPEAN JOURNAL OF VASCULAR SURGERY, 1993, 7 (03): : 301 - 307
  • [9] AORTOBIFEMORAL BYPASS WITH AUTOGENOUS SAPHENOUS-VEIN IN TREATMENT OF PANINFECTED AORTIC BIFURCATION GRAFT
    LORENTZEN, JE
    NIELSEN, OM
    [J]. JOURNAL OF VASCULAR SURGERY, 1986, 3 (04) : 666 - 668
  • [10] MASUDA EM, 1992, J VASC SURG, V16, P741